Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes
CA 2378820 A1 · Owner: Yellin, Michael J. · Inventors: Chess, Leonard; Lederman, Seth; Yellin, Michael J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides a monoclonal antibody capable of binding to a protein which is, specifically recognized by monocolonal antibody 5c8 produced by the hybridoma having ATCC, Accession No. HB 10916. This invention also provides an isolated protein which is specifically, recognized by monoclonal antibody 5c8 produced by the hybridoma having ATCC No. HB, 10916. This invention further provides an isolated nucleic acid molecule encoding a protein, which is specifically recognized by monocolonal antibody 5c8 produced by the hybridoma, having ATCC No. HB 10916. This invention also provides a human CD4-T cell leukemia cell, line designated D1.1 having ATCC Accession No. CRL 10915 …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 16, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 16, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 16, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.